Copeptin as a novel diagnostic and prognostic marker in the management of neurological and neurosurgical patients with sodium imbalance

niversity Hospital Basel (Switzerland)0 个研究点目标入组 500 人开始时间: 2006年11月21日最近更新: 2021年9月13日

试验速览

2009 Results article in https://pubmed.ncbi.nlm.nih.gov/20035506/ (added 02/09/2021) 2010 Results article in https://pubmed.ncbi.nlm.nih.gov/20846604/ (added 02/09/2021) 2013 Results article in https://pubmed.ncbi.nlm.nih.gov/23650556/ (added 02/09/2021) 2014 Results article in https://pubmed.ncbi.nlm.nih.gov/25072816/ (added 02/09/2021)

•1. All consecutive patients who are admitted to the emergency department with an ischaemic or haemorrhagic stroke or Transient Ischaemic Attack (TIA) according to the World Health Organization criteria with symptom onset within the last three days
•2. All consecutive patients who undergo intracranial surgery due to:
•a. pituitary tumors
•b. IntraCerebral Haemorrhage (ICH)
•c. SubArachnoidal Haemorrhage (SAH)
•d. chronic subdural haematoma
•e. head trauma with contusio cerebri
•f. intracranial abcesses

发起方

niversity Hospital Basel (Switzerland)